Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure

LISLE, Ill., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 millio... Devices, Cardiology, Venture Capital Endotronix, Cordella, Heart Failure System, wireless, pulmonary artery sensor
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news